硕腾(ZTS)2026年Q3营收24亿美元 同比降1%

金吾财讯
Nov 06

金吾财讯 | 硕腾(ZTS)披露2026年第三季度财报业绩与展望要点。本季度营收24亿美元,报告口径及有机口径均同比下降1%;调整后每股收益1.75美元;美国业务营收12亿美元,同比下滑6%,国际业务营收11亿美元,同比增长4%;调整后毛利率71%,环比下降30个基点,GAAP业绩包含7800万美元收购研发资产减值。公司将全年营收指引收窄至92.2亿–93.2亿美元,上调调整后稀释每股收益指引至6.25–6.35美元,上调调整后净利润指引至26亿–26.4亿美元。管理层表示暂不给出下一年度具体业绩指引,将保持审慎规划,不预设宏观环境以及宠物消费趋势好转;同时预计长效Cytopoint、Simparica Duo两款产品有望于年内在美国获批。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10